CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ:CERS) announced today that the German National Blood Advisory Committee, or the AK Blut, has advised the German Ministry of Health that the shelf-life of conventional platelet components should be shortened to four days to reduce the incidence of life-threatening septic transfusion reactions arising from potential bacterial contamination. Only pathogen-inactivated platelets, such as those treated with the INTERCEPT Blood System, are exempt from the new restriction and may be stored for five days. Cerus is working with blood centers in Germany to implement the INTERCEPT Blood System and is supporting their individual regulatory applications for sale of INTERCEPT-treated platelets.
